How aspirin halves colon cancer risk

Comment on this story


aspirin sxc

sxc.hu

Researchers previously were aware that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin could reduce colorectal cancer risks.

Washington - Aspirin can reduce the risk of colon cancer by half, but only in people who carry high levels of a specific type of gene, a study released on Wednesday found.

Researchers previously were aware that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin could reduce colorectal cancer risks, but they did not understand why some saw a benefit and others did not, according to the study in Science Translational Medicine.

Scientists studied tissues from people who developed colon cancer while on an aspirin regimen then set out to understand why people with a particular gene appeared to get a protective benefit from aspirin and others did not.

They examined tissues of 270 colon cancer patients from 127 865 participants followed for over three decades.

They found that patients who lacked a genetic profile which yields high levels of the enzyme 15-PGDH got almost no protective benefit for colon cancer from aspirin.

“If you looked at the folks from the study who had high 15-PGDH levels and took aspirin, they cut their risk of colon cancer by half,” said senior author Sanford Markowitz of Case Western Reserve School of Medicine.

Yet “if you looked at the folks from the study that were low for 15-PGDH, they did not benefit at all from taking aspirin. These findings represent a clean yes-no about who would benefit from aspirin,” he explained.

Identifying who can benefit from the colon cancer-reducing potential of aspirin is an important step because in some patients aspirin causes an increased risk of stomach ulcers and gastrointestinal bleeding, researchers said.

They are hoping to develop a test that would make it easy to identify who is and is not likely to get the positive effects of aspirin.

According to the American Cancer Society, colon cancer struck 137 000 Americans in 2014 and 50 000 will die of it. It is the second deadliest cancer after lung cancer.

But colon cancer deaths have been decreasing steadily over the past two decades as more and more people have sought testing, particularly colonoscopies. - Sapa-AFP

Hungry for more scitech news? Sign up for our daily newsletter


sign up
 
 

Comment Guidelines



  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

     

Join us on

IOL-Social networks IOL-Social networks IOL-Social networks IOL-Social networks